Plus Therapeutics, Inc. (PSTV)

NCM – Real Time Price. Currency in USD

3.87

+3.87 (0.00%)

Market open: Jul 31, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

224K

Cost of goods sold

-445K

-852K

-745K

-712K

Gross Profit

-488K

Operating expenses (excl. COGS)

-20M

-17M

-19M

Operating Income

-15M

-13M

-20M

Non-operating income, total

-7M

-563K

Pretax income

-22M

-13M

-20M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-22M

-13M

-20M

Discontinued operations

Net income

-22M

-13M

-20M

Dilution adjustment

-5M

Preferred dividends

Plus Therapeutics, Inc. (PSTV)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Plus Therapeutics, Inc. (PSTV)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Plus Therapeutics, Inc. (PSTV)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Plus Therapeutics, Inc. (PSTV)

Income Statement (Annual)

Income Statement (Annual)